drugset / Trial / NCT02449070
Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether nicorandil reduce cardiac infarct size in patient with ST-segment elevation acute myocardial infarction.
Timeline
- Start
- 2015-05
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicorandil | Other / unclassified | 5 mg | Intravenous |
| Subject | Nicorandil | Other / unclassified | 10 mg | Intravenous |